SCHEMBL2606735

SCHEMBL2606735

CCOC(=O)c1csc(SSc2nc(C)cs2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.57
NPC1 O15118 7/20 0.57
MAPT P10636 6/20 0.57
ALDH1A1 P00352 2/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
CYP1A2 P05177 2/20 0.52
CYP2C19 P33261 1/20 0.52
GAA P10253 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
POLB P06746 2/20 0.49
PKM P14618 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
HSP90AA1 P07900 2/20 0.47
LMNA P02545 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPK1 P28482 1/20 0.44
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2096075 0.94 RAB9A (0.64) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL21962990 0.88 RAB9A (0.57) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL3117692 0.83 RAB9A (0.62) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL2447269 0.77 RAB9A (0.52) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL914552 0.77 RAB9A (0.68) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL13144514 0.77 MAPT (0.70) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL22622703 0.77 RAB9A (0.46) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL2445404 0.77 RAB9A (0.55) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL2452993 0.77 RAB9A (0.58) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL5804686 0.76 SMN1; SMN2 (0.48) RAB9ANPC1MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163776-B2 Immunomodulation by administering thione-forming dithiobis-heterocyclic compound, increased natural killer cell activity, expansion of NK cell population, decreased B cell population, decreased antibody production GRASSETTI FAMILY TRUST (US) 2012-04-24 US disclosed